Free Trial

Abeona Therapeutics (ABEO) SEC Filings & 10K Form

Abeona Therapeutics logo
$5.19 -0.03 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$5.22 +0.03 (+0.67%)
As of 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Abeona Therapeutics SEC Filings

DateFilerForm TypeView
01/06/2025
4:09 PM
Abeona Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/20/2024
3:15 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:56 PM
Abeona Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:53 PM
Abeona Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
11/14/2024
8:59 AM
Abeona Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:30 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:29 PM
Abeona Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
09/30/2024
3:30 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:30 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:30 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:30 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:05 PM
Abeona Therapeutics (Issuer)
Alland Leila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:06 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:07 PM
Abeona Therapeutics (Issuer)
Amoroso Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:08 PM
Abeona Therapeutics (Issuer)
Charles Faith L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:09 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:10 PM
Abeona Therapeutics (Issuer)
Wuchterl Donald A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:35 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
3:30 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:30 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Alland Leila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Charles Faith L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Amoroso Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:35 PM
Abeona Therapeutics (Issuer)
Wuchterl Donald A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:56 PM
Abeona Therapeutics (Filer)
Form 424B5
06/20/2024
11:15 PM
Abeona Therapeutics (Filer)
Form EFFECT
06/20/2024
3:30 PM
Abeona Therapeutics (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:30 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:17 PM
Abeona Therapeutics (Filer)
Form S-3/A
06/17/2024
3:47 PM
Abeona Therapeutics (Subject)
Alvino Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:47 PM
Abeona Therapeutics (Subject)
Silverstein Christine Berni (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
AAPL: Double Your Returns in 24 Hours? (Ad)

Trader Chris Pulver is diving deep into the inner workings of Wall Street... To reveal a trading method he’s kept under wraps for years. You see… Thanks to “liquidity levels” which show us Wall Street’s biggest undercover buy orders in real time… This method has shown the ability to DOUBLE our returns…

You can see them—along with the finer details of how his strategy works—on this page right here.
06/12/2024
6:01 AM
Abeona Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
3:32 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:33 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:31 PM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:30 PM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:30 PM
Abeona Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
Form SC 13G/A
05/20/2024
7:30 AM
Abeona Therapeutics (Issuer)
Alland Leila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:35 AM
Abeona Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
6:30 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:03 PM
Abeona Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
05/09/2024
2:06 PM
Abeona Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
05/08/2024
3:15 PM
Abeona Therapeutics (Issuer)
Adage Capital Management, L.P. (Reporting)
Atchinson Robert (Reporting)
Gross Phillip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:45 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:30 AM
Abeona Therapeutics (Issuer)
Charles Faith L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:30 AM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
7:30 AM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
7:30 AM
Abeona Therapeutics (Issuer)
O'Malley Brendan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:05 PM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:19 AM
Abeona Therapeutics (Filer)
Form DEF 14A
03/18/2024
7:36 AM
Abeona Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:35 AM
Abeona Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2024
4:00 PM
Abeona Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:38 PM
Abeona Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/12/2024
4:23 PM
Abeona Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/07/2024
7:30 AM
Abeona Therapeutics (Issuer)
Seshadri Vishwas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:30 PM
Abeona Therapeutics (Issuer)
Alvino Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners